Sernova (TSE:SVA) Issues Quarterly Earnings Results

Sernova (TSE:SVA) issued its earnings results on Thursday. The company reported C($0.01) earnings per share for the quarter, FiscalAI reports.

Sernova Price Performance

Sernova stock remained flat at C$0.14 during trading hours on Thursday. The company’s stock had a trading volume of 500,864 shares, compared to its average volume of 125,710. The company has a current ratio of 0.14, a quick ratio of 18.11 and a debt-to-equity ratio of -25.45. The company has a market capitalization of C$52.87 million, a PE ratio of -3.50 and a beta of -0.43. Sernova has a 1 year low of C$0.10 and a 1 year high of C$0.20. The business has a 50 day moving average of C$0.11 and a 200 day moving average of C$0.14.

About Sernova

Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem-cell derived islet-like clusters in collaboration with Evotec to create bio-hybrid organs to treat T1D. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This innovative approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on T1D and thyroid disorders.